triazoles has been researched along with clonazepam in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, JM; Olson, MS; Svetlov, SI | 1 |
| Adler, LA; Angrist, B; Eberstein, S | 1 |
| Benazzi, F | 1 |
| Czuczwar, SJ; Luszczki, JJ; Patsalos, PN; Ratnaraj, N | 1 |
| Huguenard, JR; Huntsman, MM | 1 |
| Hopfgartner, G; Le Blanc, JC; Varesio, E | 1 |
| Awaya, T; Heike, T; Ide, M; Kato, T; Nakata, M; Saito, K; Yoshida, T | 1 |
| García-Peñas, JJ; Gil Nagel-Rein, A; Sánchez-Carpintero, R; Villanueva-Haba, V | 1 |
1 review(s) available for triazoles and clonazepam
| Article | Year |
|---|---|
Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Clonazepam; Diazepam; Dioxolanes; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Phenobarbital; Practice Guidelines as Topic; Pyrrolidinones; Spain; Triazoles; Valproic Acid | 2021 |
7 other study(ies) available for triazoles and clonazepam
| Article | Year |
|---|---|
The specific binding of the platelet-activating factor (PAF) receptor antagonist WEB 2086 and the benzodiazepine flunitrazepam to rat hepatocytes.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Azepines; Benzodiazepinones; Bicuculline; Cells, Cultured; Clonazepam; Convulsants; Flunitrazepam; Kinetics; Liver; Male; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles; Tritium | 1996 |
Nefazodone and akathisia.
Topics: Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Clonazepam; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Propranolol; Triazoles | 1996 |
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypotension; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride | 1997 |
Pharmacodynamic and/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis.
Topics: Animals; Anticonvulsants; Clonazepam; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Ethosuximide; Kindling, Neurologic; Linear Models; Male; Mice; Pentylenetetrazole; Phenobarbital; Seizures; Triazoles; Valproic Acid | 2005 |
Fast IPSCs in rat thalamic reticular nucleus require the GABAA receptor beta1 subunit.
Topics: Animals; Clonazepam; Electrophysiology; Excitatory Postsynaptic Potentials; Female; GABA Modulators; Intralaminar Thalamic Nuclei; Male; Neurons; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Synapses; Triazoles | 2006 |
Real-time 2D separation by LC × differential ion mobility hyphenated to mass spectrometry.
Topics: Aminoquinolines; Benzimidazoles; Bromazepam; Chlorprothixene; Chromatography, High Pressure Liquid; Clonazepam; Fendiline; Humans; Mass Spectrometry; Oxycodone; Silanes; Time Factors; Triazoles | 2012 |
A granulocytosis associated with rufinamide: A case report.
Topics: Agranulocytosis; Anticonvulsants; Child; Clonazepam; Epilepsy; Humans; Male; Triazoles; Valproic Acid | 2015 |